Related Experiment Video
Updated: May 12, 2026

Ischemia-reperfusion Model of Acute Kidney Injury and Post Injury Fibrosis in Mice
Published on: August 9, 2013
Serum cystatin C is associated with renal function recovery in critically ill patients undergoing continuous renal
1Department of Critical Care Medicine, Jinhua Municipal Central Hospital, Jinhua Hospital of Zhejiang University, Jinhua, China. zh_zhang184 @ hotmail.com
Purpose:
Serum cystatin C (sCyC) has long been known as a reliable biomarker of renal injury. However, it remains to be tested whether sCyC is a reliable biomarker to predict renal recovery after continuous renal replacement therapy (CRRT).
Methods:
A retrospective analysis of patients admitted to a tertiary 18-bed intensive care unit from January 2008 to December 2011 was performed. Univariate and multivariate regression analyses were performed to test the independent predictors of renal recovery. The diagnostic value of sCyC in predicting renal recovery was assessed using a receiver operating characteristic curve (ROC).
Results:
Older age and higher sCyC were independent risk factors of renal nonrecovery (OR: 1.40 and 4.76, respectively). The area under the ROC of sCyC to predict renal recovery was 0.87 (95% CI: 0.82-0.92), with a sensitivity and specificity of 80.5% and 83.5% at the cutoff of 2.98 mg/l.
Conclusion:
A high sCyC level at the initiation of CRRT is associated with poor renal outcome.
Related Concept Videos
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Serum Studies: Renal Function Tests
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury V: Interprofessional Care